French Stock Market Authority Clearance Decision Regarding the Mandatory Tender Offer by CAMLIN FINE SCIENCES on Vinpai Shares
Release of the offer document and other information document
Regulatory News:
This press release must not be published, distributed or transmitted, directly or indirectly, in the United States of America, Australia, Canada, South Africa or Japan.
CAMLIN FINE SCIENCES LIMITED, a leading Indian group in shelf life solutions for flavour and health & wellness ingredients, listed on the National Stock Exchange of India Ltd and BSE Ltd. in Mumbai India (“CFSL”) reminds that it has completed the acquisition on November 27, 2025, by way of contribution in kind, of a majority stake in the share capital of Vinpai (ISIN: FR001400AXT1; mnémonique : ALVIN) representing 78.68% of share capital and 84.89% of voting rights of Vinpai, at a price of EUR 3.60 per Vinpai share (the “Block Acquisition”) from majority shareholders (the “Sellers”) and proceeded to the conversion of the convertible bonds (the “Convertible Bonds”), allowing it to subscribe to 1,100,000 new ordinary shares of Vinpai, that were issued to it.1
